Comunicato Stampa: La Sorgente del tempo. Sintetica introduce una nuova forma di People Care pensata per l’accudimento di familiari bisognosi di cure e assistenza. 22 May 2023
COMUNICATO STAMPA – Waldo Mossi eletto Vicepresidente di Farma Industria Ticino per il triennio 2022-2025 28 September 2022
The 3rd Sustainability Report confirms IBSA’s commitment to the well-being of the Person 20 December 2021
DA IBSA OLTRE 700.000 CHF PER COMBATTERE L’EMERGENZA COVID-19 DI QUESTI 245.000 CHF DONATI DAI LAVORATORI IBSA A SOSTEGNO DELLE FAMIGLIE IN DIFFICOLTÀ 13 May 2020
Helsinn and MEI Pharma Announce Updated Clinical Data from the Phase 2 Study Evaluating Pracinostat in Combination with Azacitidine in Patients with High/Very-high Risk Myelodysplastic Syndromes 13 May 2020
IBSA DONA ALL’UFFICIO DEL MEDICO CANTONALE I TEST SIEROLOGICI PER L’INDIVIDUAZIONE DEGLI ANTICORPI AL COVID-19 8 May 2020
Farma Industria Ticino realizza una filiera produttiva locale di etanolo donando 940 litri all’EOC 23 April 2020
Helsinn Therapeutics (U.S.), Inc. waives copay fees for cancer-treating drug VALCHLOR® (mechlorethamine) gel to ensure eligible patients have access to treatment during the COVID-19 crisis 20 April 2020
IBSA JOINS THE FIGHT AGAINST COVID-19: DONATION OF CHF 500,000 AND MEDICAL SUPPLIES TO HELP THE MOST AFFECTED AREAS 6 April 2020
Linkedin